MultiPlan Corp (NYSE:MPLN)

$ 0.3665 -0.0165 (-4.31%) Market Cap: 236.34 Mil Enterprise Value: 4.72 Bil PE Ratio: 0 PB Ratio: 0.20 GF Score: 55/100

Q1 2024 Multiplan Corp Earnings Call Transcript
May 08, 2024

$0.6072 (-6.60%)

Earnings
Q4 2023 Multiplan Corp Earnings Call Transcript
Feb 29, 2024

$1.12

Earnings
Multiplan Corp at JPMorgan Healthcare Conference Transcript
Jan 09, 2024
Q3 2023 Multiplan Corp Earnings Call Transcript
Nov 07, 2023

$1.44 (-6.49%)

Earnings
Multiplan Corp at Deutsche Bank Leveraged Finance Conference Transcript
Oct 03, 2023
Multiplan Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 11, 2023
Q2 2023 Multiplan Corp Earnings Call Transcript
Aug 02, 2023

$1.95 (-8.88%)

Earnings
Multiplan Corp Analyst and Investor Day Transcript
Jun 28, 2023
Q1 2023 Multiplan Corp Earnings Call Transcript
May 04, 2023

$0.7227 (-13.43%)

Earnings
Multiplan Corp at Barclays Global Healthcare Conference Transcript
Mar 14, 2023
Multiplan Corp at Citi Healthcare & Medtech Conference Transcript
Mar 02, 2023
Q4 2022 Multiplan Corp Earnings Call Transcript
Feb 28, 2023

$1.01 (+1.00%)

Earnings
Multiplan Corp at Bank of America Leveraged Finance/Credit Conference Transcript
Nov 29, 2022
Q3 2022 Multiplan Corp Earnings Call Transcript
Nov 08, 2022

$2 (-17.01%)

Earnings
Multiplan Corp at Deutsche Bank Leveraged Finance Conference Transcript
Sep 20, 2022
Multiplan Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
Q2 2022 Multiplan Corp Earnings Call Transcript
Aug 04, 2022

$4.47 (-10.78%)

Earnings
Multiplan Corp at Goldman Sachs Leveraged Finance and Credit Conference Transcript
May 12, 2022
Q1 2022 Multiplan Corp Earnings Call Transcript
May 10, 2022

$4.61 (+11.89%)

Earnings
Multiplan Corp Annual Shareholders Meeting Transcript
Apr 26, 2022
Multiplan Corp at Barclays Global Healthcare Conference Transcript
Mar 16, 2022
Multiplan Corp at Citi Healthcare Conference (Virtual) Transcript
Feb 23, 2022
Q4 2021 Multiplan Corp Earnings Call Transcript
Feb 17, 2022

$4.43 (-4.73%)

Earnings
Multiplan Corp at Bank of America Leveraged Finance Conference (Virtual) Transcript
Dec 01, 2021
Multiplan Corp at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 11, 2021
Multiplan Corp Address Recent Volatility in the Stock Call Transcript
Nov 08, 2021
Q3 2021 Multiplan Corp Earnings Call Transcript
Nov 03, 2021

$4.76 (+7.21%)

Earnings
Q2 2021 Multiplan Corp Earnings Call Transcript
Aug 05, 2021

$7.22 (-6.48%)

Earnings
Multiplan Corp Annual Shareholders Meeting Transcript
May 27, 2021
Q1 2021 Multiplan Corp Earnings Call Transcript
May 13, 2021

$7.15 (+16.26%)

Earnings
Q4 2020 Multiplan Corp Earnings Call Transcript
Mar 10, 2021

$6.25 (-19.67%)

Earnings
Q3 2020 Multiplan Corp Earnings Call Transcript
Nov 12, 2020

$6.27 (-10.56%)

Earnings
Multiplan Corp Analyst Day Transcript
Aug 18, 2020

Multiplan Corp Analyst Day Transcript

Aug 18, 2020 / 01:00PM GMT

Transcript 10-Q

Shawna Gasik

Good morning. At this time, I would like to welcome everyone to the MultiPlan Sell-side Analyst Day Presentation. (Operator Instructions)

The company will hold the Q&A at the end of the scheduled presentations. Thank you.

Mark Howard Tabak

MultiPlan Corporation - President, CEO & Chairman

Welcome, everyone, to MultiPlan's first-ever analyst day presentation. We're really excited to share the MultiPlan story today and present our strategy for the future as a public company. MultiPlan is a leading value-added provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. health care industry. Our primary mission is to make health care in the U.S. affordable, accessible, efficient and fair to the 3 constituencies we serve: patients, providers and payers.

Our services and business processes are aligned with this goal. We provide a mission-critical service and are recognized as a truly independent source of trusted information to the U.S. health care industry. We are the leader in added network

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.